Kirtland Poss
Consultant / Advisor chez Edgewater Capital Partners
Profil
Kirtland G.
Poss is the founder of VisEn Medical, Inc. (founded in 2000) where he held the title of President & Chief Executive Officer from 2011 to 2013.
He was also the founder of ProtaGene US, Inc. (founded in 2012) where he served as President, Chief Executive Officer & Director from 2012 to 2021.
Currently, Dr. Poss is an Executive Advisor at Edgewater Capital Partners since 2023.
In the past, Dr. Poss worked as the Chief Executive Officer at ProtaGene GmbH from 2021 to 2022.
He also held positions as a Principal at Boston Scientific Corp., Revvity, Inc., The General Hospital Corp., Molecular Imaging, Inc., and Harvard Medical School.
Dr. Poss completed his undergraduate degree at the University of Connecticut in 1992.
Postes actifs de Kirtland Poss
| Sociétés | Poste | Début |
|---|---|---|
Edgewater Capital Partners
 Edgewater Capital Partners Investment ManagersFinance Edgewater Capital Partners (Edgewater Capital Partners) is a private equity firm founded in 1998 by Christopher F. Childres and Edward L. Sawyer. The firm is headquartered in Cleveland, Ohio. | Consultant / Advisor | 01/04/2023 |
Anciens postes connus de Kirtland Poss
| Sociétés | Poste | Fin |
|---|---|---|
Protagene CGT GmbH
 Protagene CGT GmbH BiotechnologyHealth Technology Protagene CGT GmbH engages in the development of research concepts and platforms for DNA and RNA fusion sequences. Its products include Vector safety, AAV Vector quality control, immune repertoire analyses, target analyses in gene editing, as well as bioinformatics and next generation sequencing. The company was founded by Christof von Kalle, Manfred Schmidt, and Annette Deichmann in July 2014 and is headquartered in Heidelberg, Germany. | Directeur Général | 30/09/2022 |
BioAnalytix, Inc.
 BioAnalytix, Inc. Information Technology ServicesTechnology Services BioAnalytix, Inc. develops and applies advanced analytic technologies. It offers advanced analytics, biologic therapeutics, mass spec, drug development and biopharma technologies. The company was founded by Barry L. Karger and Kirtland G. Poss in 2012 and is headquartered in Cambridge, MA. | Fondateur | 01/07/2021 |
VisEn Medical, Inc.
 VisEn Medical, Inc. Medical/Nursing ServicesHealth Services VisEn's in vivo fluorescence imaging technologies, including its Fluorescence Agent Portfolio and its Fluorescence Molecular Tomographic (FMTTM) Imaging Systems provide robust fluorescence molecular imaging performance in identifying, characterizing and quantifying ranges of disease biomarkers and therapeutic efficacy in vivo. VisEn's FMT systems and agents are used by leading research institutions and pharmaceutical companies in applications including cancer research, inflammation, cardiovascular, skeletal and pulmonary disease. The company also works with large pharmaceutical partners to design ranges of tailored molecular imaging agents and applications that are designed to their specific pre-clinical and clinical research areas. | Fondateur | 26/07/2013 |
| Harvard Medical School | Corporate Officer/Principal | - |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Formation de Kirtland Poss
| University of Connecticut | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| REVVITY, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
VisEn Medical, Inc.
VisEn Medical, Inc. Medical/Nursing ServicesHealth Services VisEn's in vivo fluorescence imaging technologies, including its Fluorescence Agent Portfolio and its Fluorescence Molecular Tomographic (FMTTM) Imaging Systems provide robust fluorescence molecular imaging performance in identifying, characterizing and quantifying ranges of disease biomarkers and therapeutic efficacy in vivo. VisEn's FMT systems and agents are used by leading research institutions and pharmaceutical companies in applications including cancer research, inflammation, cardiovascular, skeletal and pulmonary disease. The company also works with large pharmaceutical partners to design ranges of tailored molecular imaging agents and applications that are designed to their specific pre-clinical and clinical research areas. | Health Services |
Molecular Imaging, Inc.
 Molecular Imaging, Inc. Miscellaneous Commercial ServicesCommercial Services Molecular Imaging, Inc. provides research services supported by extensive in vivo imaging capabilities. Its services include oncology pharmacology, immuno-oncology, imaging, radiation, and in vivo biodistribution. The company was founded by Wilbur R. Leopold, John Fleming, and Patrick McConville in 2003 and is headquartered in Ann Arbor, MI. | Commercial Services |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
BioAnalytix, Inc.
BioAnalytix, Inc. Information Technology ServicesTechnology Services BioAnalytix, Inc. develops and applies advanced analytic technologies. It offers advanced analytics, biologic therapeutics, mass spec, drug development and biopharma technologies. The company was founded by Barry L. Karger and Kirtland G. Poss in 2012 and is headquartered in Cambridge, MA. | Technology Services |
Edgewater Capital Partners
Edgewater Capital Partners Investment ManagersFinance Edgewater Capital Partners (Edgewater Capital Partners) is a private equity firm founded in 1998 by Christopher F. Childres and Edward L. Sawyer. The firm is headquartered in Cleveland, Ohio. | Finance |
Protagene CGT GmbH
Protagene CGT GmbH BiotechnologyHealth Technology Protagene CGT GmbH engages in the development of research concepts and platforms for DNA and RNA fusion sequences. Its products include Vector safety, AAV Vector quality control, immune repertoire analyses, target analyses in gene editing, as well as bioinformatics and next generation sequencing. The company was founded by Christof von Kalle, Manfred Schmidt, and Annette Deichmann in July 2014 and is headquartered in Heidelberg, Germany. | Health Technology |